Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
SDZ-62-434
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
YH-1238
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
DS-6930
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
VBY-825
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
Z LVG CHN2
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
ONO 5334
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
MLN-3897
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
Lividomycin
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Edotecarin
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Quisinostat
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Spirofylline
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Diniprofylline
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Fluprofylline
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Burixafor
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Quinoline,1,2,3,4-tetrahydro-1-[(2-phenylcyclopropyl)sulfonyl]-trans-(8CI)
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Rilapladib
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
Oxolinic acid
Potential treatment - theoretical effect Experimental Antiviral Jul/23/2020
ARCoV
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/23/2020
4-[(pyridin-3-ylmethyl) amino]-2H-chromen-2-one
Potential treatment - theoretical effect Experimental Antiviral Jul/16/2020
Azvudine
Potential treatment - clinical evidence Experimental Antiviral Jul/14/2020